These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19806853)

  • 1. Predictors, barriers, and facilitators of lipid-lowering medication use among African Americans in a primary care clinic.
    Schwartz KL; Dailey R; Bartoces M; Binienda J; Archer C; Neale AV
    J Natl Med Assoc; 2009 Sep; 101(9):944-52. PubMed ID: 19806853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT).
    Margolis KL; Dunn K; Simpson LM; Ford CE; Williamson JD; Gordon DJ; Einhorn PT; Probstfield JL;
    Am Heart J; 2009 Dec; 158(6):948-55. PubMed ID: 19958861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial differences in medication adherence: A cross-sectional study of Medicare enrollees.
    Gerber BS; Cho YI; Arozullah AM; Lee SY
    Am J Geriatr Pharmacother; 2010 Apr; 8(2):136-45. PubMed ID: 20439063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of lipid-lowering therapy and factors affecting regularity of statin intake in patients with cardiovascular disease enrolled in the PROFILE registry.
    Gaisenok O; Martsevich S; Tripkosh S; Lukina Y
    Rev Port Cardiol; 2015 Feb; 34(2):111-6. PubMed ID: 25660463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitators and barriers to adherence to urate-lowering therapy in African-Americans with gout: a qualitative study.
    Singh JA
    Arthritis Res Ther; 2014 Mar; 16(2):R82. PubMed ID: 24678765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Blood Pressure Medication Adherence Among Urban, African Americans in the Midwest United States.
    Schober DJ; Tate M; Rodriguez D; Ruppar TM; Williams J; Lynch E
    J Racial Ethn Health Disparities; 2021 Jun; 8(3):607-617. PubMed ID: 32651883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Affecting Adherence to Statins in Hypercholesterolemic Kuwaiti Patients: A Cross-Sectional Study.
    Al-Foraih M; Somerset S
    Med Princ Pract; 2017; 26(1):35-40. PubMed ID: 27607329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Relationship Among Health Beliefs, Depressive Symptoms, Medication Adherence, and Social Support in African Americans With Hypertension.
    Spikes T; Higgins M; Quyyumi A; Reilly C; Pemu P; Dunbar S
    J Cardiovasc Nurs; 2019; 34(1):44-51. PubMed ID: 30273259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study.
    Massing MW; Foley KA; Carter-Edwards L; Sueta CA; Alexander CM; Simpson RJ
    BMC Cardiovasc Disord; 2004 Aug; 4():15. PubMed ID: 15317654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is lipid-lowering therapy underused by African Americans at high risk of coronary heart disease within the VA health care system?
    Woodard LD; Kressin NR; Petersen LA
    Am J Public Health; 2004 Dec; 94(12):2112-7. PubMed ID: 15569962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Provider adherence to clinical guidelines related to lipid-lowering medications.
    Cohen SM; Kataoka-Yahiro M
    Mil Med; 2010 Feb; 175(2):122-6. PubMed ID: 20180482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary heart disease and lipid-modifying treatment in African American patients.
    Ferdinand KC
    Am Heart J; 2004 May; 147(5):774-82. PubMed ID: 15131530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Awareness, treatment, and control of vascular risk factors in African Americans with stroke.
    Ruland S; Raman R; Chaturvedi S; Leurgans S; Gorelick PB;
    Neurology; 2003 Jan; 60(1):64-8. PubMed ID: 12525719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 15. Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients.
    Mark TL; Axelsen KJ; Mucha L; Sadkova Y
    Am J Manag Care; 2007 Jun; 13 Suppl 3():S72-9. PubMed ID: 17596115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to National Cholesterol Education Program Treatment goals in postmenopausal women with heart disease. The Heart and Estrogen/Progestin Replacement Study (HERS). The HERS Research Group.
    Schrott HG; Bittner V; Vittinghoff E; Herrington DM; Hulley S
    JAMA; 1997 Apr 23-30; 277(16):1281-6. PubMed ID: 9109465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering drug adherence and combination therapy effects on gastrointestinal cancer in patients with dyslipidemia without diabetes: a retrospective cohort study in South Korea.
    Han KT; Kim S
    BMC Cancer; 2022 Feb; 22(1):156. PubMed ID: 35135497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glaucoma medication adherence among African Americans: program development.
    Dreer LE; Girkin CA; Campbell L; Wood A; Gao L; Owsley C
    Optom Vis Sci; 2013 Aug; 90(8):883-97. PubMed ID: 23873033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
    ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
    JAMA; 2002 Dec; 288(23):2998-3007. PubMed ID: 12479764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Automated outreach to increase primary adherence to cholesterol-lowering medications.
    Derose SF; Green K; Marrett E; Tunceli K; Cheetham TC; Chiu VY; Harrison TN; Reynolds K; Vansomphone SS; Scott RD
    JAMA Intern Med; 2013 Jan; 173(1):38-43. PubMed ID: 23403978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.